Software Engineering & Applied Research — Margaret River, WA

The software, the AI layer, and the integration underneath deep technology products.

Queensberry builds the engineering that sits underneath deep technology products and holds the intellectual property behind them — including our own platform, metabolica.app, a clinical point-of-care insulin diagnostic platform.

Our Capabilities Visit metabolica.app →
3 Decades delivering production systems across banking, manufacturing, resources & tourism
20+ Years technology delivery from Margaret River, WA
$50K Innovation Booster Grant 2026 recipient

Queensberry

Queensberry is a software engineering and applied research company based in Margaret River, Western Australia. The registered entity is Queensberry Consulting Pty Ltd.

We build the software, the AI layer and the integration work that sits underneath deep technology products, and we hold the intellectual property behind them.

Our directors have spent three decades delivering production systems across enterprise banking, manufacturing, resources and tourism. That history shapes how we work now: careful engineering, real users, and systems that survive contact with the field.

Client Engineering

Custom application development on modern cloud native stacks, including Angular, React, TypeScript and AWS. We work in sectors where the data is messy, the domain is technical and the answer has to be defensible.

Applied AI & Integration

Predictive and machine learning layers built on real clinical and operational data, and the integration work that connects instruments, wearables, devices and records into something a practitioner can actually use.

One team. Multiple capabilities.

From client engineering to applied AI and integration, Queensberry brings the same rigorous, technically-led approach to every engagement — including our own product, Metabolica.

Metabolica — metabolica.app

Built in-house by Queensberry, Metabolica is the first platform globally to combine real-time point-of-care insulin measurement, multi-device wearable biometric data, and AI-powered metabolic risk prediction in a single clinician-accessible platform.

1

Finger-prick insulin test

The Lumos Diagnostics POC reader measures fasting insulin from a single blood drop in under 5 minutes — at the point of care, no laboratory required.

2

Wearable data sync

Continuous glucose, HRV, sleep quality and activity data pulled via API from 15+ wearable platforms including Garmin, Apple Health, Oura, Whoop and Dexcom.

3

AI metabolic analysis

Combined insulin and biometric data is processed by a machine learning model generating a personalised metabolic risk profile, updated in real time.

4

Clinician dashboard

Results displayed in a secure clinician-accessible dashboard, enabling remote monitoring, trend analysis, and metabolic risk assessment over time.

Who uses Metabolica

GPs & Specialists

In-clinic metabolic screening and remote monitoring for at-risk patients.

Anaesthetists

Perioperative metabolic risk assessment — insulin resistance as a modifiable surgical risk factor.

Corporates

Workforce metabolic health baseline and evidence-based prevention program support.

Community Programs

Population health monitoring for community sport, regional health, and chronic disease prevention.

Visit metabolica.app →

Innovation Booster Grant 2026

Queensberry Consulting Pty Ltd was named a recipient of the Innovation Booster Grant 2026, a Western Australian Government program administered by the Department of Energy and Economic Diversification to back early-stage founders and innovation-driven SMEs to strengthen capability and commercialise innovative projects.

$50,000
Innovation Booster Grant 2026
Awarded for Metabolica — Clinical Point-of-Care Insulin Diagnostic Platform.
Awarded — 2026
Department of Energy and Economic Diversification, Government of Western Australia Program administered by the Department of Energy and Economic Diversification, Government of Western Australia.
View the 2026 recipients list →

Directors

Queensberry is led by three directors with complementary expertise across biomedical science, software engineering, financial management, and technology commercialisation.

Craig Fisher
BSc Agricultural Science (Animal Science & Biochemistry) | PGDip Environmental Engineering | Masters of Biomedical Science (in progress)
Director — Research & Product Development
Craig is the founder and lead researcher of Metabolica. His biochemistry and biomedical science background underpins the clinical research design. He is completing a Masters of Biomedical Science focused on haemochromatosis and metabolic liver health, bringing three decades of experience delivering production technology systems to the platform's design.
Cinde Fisher
BSc Computer Science & Financial Accounting (Rhodes University) | CPA Australia | AICD Company Directors Course | Women & Leadership Australia Advanced Leadership Program
Director — Finance, Operations & Governance
Cinde brings executive leadership, financial management, and technology commercialisation experience to Queensberry. She previously secured and managed a COMET commercialisation grant and AusIndustry R&D Tax Concessions. She is Deputy Chair of Augusta Margaret River Bendigo Community Bank.
Kirra Fisher
BSc Computer Science & Accounting, University of Western Australia (2017–2020)
Director — Software Development & Platform Architecture
Kirra is a software engineer with 4+ years of professional experience in Angular, AWS, TypeScript, and cloud-based application development. At Queensberry, Kirra leads Metabolica platform software development — including wearable API integrations, authentication systems, and the clinical dashboard.

Contact Us

We welcome enquiries from practitioners, corporates, research partners, and investors.

📍

Address
47 Sheridan Road, Margaret River WA 6285

📞

Phone
0401 557 671

🌐

Platform
metabolica.app

📋

ABN
78 108 548 269

Practitioner enquiries

If you are a GP, anaesthetist, exercise physiologist, or metabolic health specialist interested in the Metabolica platform for clinical use or the validation study, please email info@queensberryconsulting.com.au with the subject line Practitioner Enquiry.

Research & partnership enquiries

For CRC-P partnership, FHRI research collaboration, or corporate wellness pilot enquiries, please email with the subject line Research Partnership or Corporate Enquiry.